RAD51

Home DNA Damage/DNA Repair RAD51

RAD51 Products

  • All (6)
  • RAD51 Inhibitors (4)
  • RAD51 Activator (1)
  • New RAD51 Products
Catalog No. Product Name Information Product Use Citations Product Validations
S2871 T0070907 T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
Front Pharmacol, 2025, 16:1559446
Sci Rep, 2025, 15(1):17232
Immunity, 2024, 57(10):2344-2361.e7
T0070907 Customer Review
S1244 Amuvatinib (MP-470) Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.
Cancer Res, 2025, 10.1158/0008-5472.CAN-24-2220
bioRxiv, 2024, 2023.11.21.568071
Microbiol Spectr, 2023, e0510522.
Amuvatinib (MP-470) Customer Review
S8077 RI-1 RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.
Cell Rep Med, 2025, 6(8):102284
MedComm (2020), 2024, 5(8):e690
Cell Death Discov, 2024, 10(1):434
RI-1 Customer Review
S8234 RS-1 RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer that enhances Cas9- and TALEN-mediated knock-in efficiency in rabbit embryos both in vitro and in vivo.
J Biomed Sci, 2024, 31(1):68
Int J Biol Sci, 2021, 17(4):1026-1040
Chembiochem, 2021, 22(20):2957-2965
F1110 Rad51 Antibody [H22D22] Rad51
S9941New Emzadirib Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.
S2871 T0070907 T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
Front Pharmacol, 2025, 16:1559446
Sci Rep, 2025, 15(1):17232
Immunity, 2024, 57(10):2344-2361.e7
 Verified customer review of T0070907
S1244 Amuvatinib (MP-470) Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.
Cancer Res, 2025, 10.1158/0008-5472.CAN-24-2220
bioRxiv, 2024, 2023.11.21.568071
Microbiol Spectr, 2023, e0510522.
 Verified customer review of Amuvatinib (MP-470)
S8077 RI-1 RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.
Cell Rep Med, 2025, 6(8):102284
MedComm (2020), 2024, 5(8):e690
Cell Death Discov, 2024, 10(1):434
 Verified customer review of RI-1
S9941New Emzadirib Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.
S8234 RS-1 RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer that enhances Cas9- and TALEN-mediated knock-in efficiency in rabbit embryos both in vitro and in vivo.
J Biomed Sci, 2024, 31(1):68
Int J Biol Sci, 2021, 17(4):1026-1040
Chembiochem, 2021, 22(20):2957-2965
S9941New Emzadirib Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.

Choose Selective RAD51 Inhibitors